These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23857878)
21. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers. Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315 [TBL] [Abstract][Full Text] [Related]
22. Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data. Choi BJ; Koo Y; Kim TY; Lim HS; Yoon D PLoS One; 2022; 17(1):e0263117. PubMed ID: 35100302 [TBL] [Abstract][Full Text] [Related]
23. Short QT syndrome: pharmacological treatment. Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889 [TBL] [Abstract][Full Text] [Related]
24. Sibutramine-associated QT interval prolongation and cardiac arrest. Ernest D; Gershenzon A; Corallo CE; Nagappan R Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104 [TBL] [Abstract][Full Text] [Related]
25. Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis. Iribarren C; Round AD; Peng JA; Lu M; Klatsky AL; Zaroff JG; Holve TJ; Prasad A; Stang P Ann Noninvasive Electrocardiol; 2014 Sep; 19(5):490-500. PubMed ID: 24829126 [TBL] [Abstract][Full Text] [Related]
26. Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients. Schächtele S; Tümena T; Gaßmann KG; Fromm MF; Maas R PLoS One; 2016; 11(5):e0155649. PubMed ID: 27192430 [TBL] [Abstract][Full Text] [Related]
27. [Acquired long QT syndrome]. Zürcher JP; Schlaepfer J; Waeber G; Pasquier M Rev Med Suisse; 2013 Aug; 9(395):1538-42. PubMed ID: 24024425 [TBL] [Abstract][Full Text] [Related]
28. Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis. Chung AK; Chua SE J Psychopharmacol; 2011 May; 25(5):646-66. PubMed ID: 20826552 [TBL] [Abstract][Full Text] [Related]
29. Borderline and Long QT Syndrome in Adolescent Athletes Taking Medications. Hoyte C; Terhune E; Carry P; McCanta A; Coel R J Adolesc Health; 2015 Aug; 57(2):218-21. PubMed ID: 26206443 [TBL] [Abstract][Full Text] [Related]
30. Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers. Kori S; Kellerman DJ; Voloshko P; Haugen G Clin Ther; 2012 Sep; 34(9):1920-8. PubMed ID: 22917853 [TBL] [Abstract][Full Text] [Related]
31. Diseases and drugs causing prolongation of the QT interval. Laakso M; Aberg A; Savola J; Pentikäinen PJ; Pyörälä K Am J Cardiol; 1987 Apr; 59(8):862-5. PubMed ID: 3825950 [TBL] [Abstract][Full Text] [Related]
32. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study. de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462 [TBL] [Abstract][Full Text] [Related]
33. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Fanoe S; Hvidt C; Ege P; Jensen GB Heart; 2007 Sep; 93(9):1051-5. PubMed ID: 17344330 [TBL] [Abstract][Full Text] [Related]
34. A case series of drug-induced long QT syndrome and Torsade de Pointes. Tong KL; Lau YS; Teo WS Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578 [TBL] [Abstract][Full Text] [Related]
35. Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice. Keller GA; Alvarez PA; Ponte ML; Belloso WH; Bagnes C; Sparanochia C; Gonzalez CD; Villa Etchegoyen MC; Diez RA; Di Girolamo G Curr Drug Saf; 2016; 11(1):86-98. PubMed ID: 26537523 [TBL] [Abstract][Full Text] [Related]
36. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Perrin-Terrin A; Pathak A; Lapeyre-Mestre M Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488 [TBL] [Abstract][Full Text] [Related]
38. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and determinants of QT interval prolongation in medical inpatients. Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787 [TBL] [Abstract][Full Text] [Related]
40. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]